Overview

A Study of Continuous Heart Rate Monitoring in Healthy Participants

Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
The main purpose of this study in healthy participants is to find out whether a heart rate monitor will accurately pick up changes in heart rate caused by 2 different medications (pseudoephedrine and metoprolol), on the background of daily activities. Participants will wear a patch heart rate and activity monitor on the chest for the entire study. The study will last about 36 days and may include up to seven visits to the study center.
Phase:
N/A
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Ephedrine
Propranolol
Pseudoephedrine